CN118662754A - Intermediate catheter assembly and conveying system - Google Patents
Intermediate catheter assembly and conveying system Download PDFInfo
- Publication number
- CN118662754A CN118662754A CN202411161768.7A CN202411161768A CN118662754A CN 118662754 A CN118662754 A CN 118662754A CN 202411161768 A CN202411161768 A CN 202411161768A CN 118662754 A CN118662754 A CN 118662754A
- Authority
- CN
- China
- Prior art keywords
- bending
- intermediate catheter
- catheter assembly
- wall
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005452 bending Methods 0.000 claims abstract description 193
- 239000002775 capsule Substances 0.000 claims abstract description 35
- 239000002872 contrast media Substances 0.000 claims abstract description 26
- 239000007924 injection Substances 0.000 claims abstract description 20
- 238000002347 injection Methods 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000002504 physiological saline solution Substances 0.000 claims abstract description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 3
- 239000003292 glue Substances 0.000 claims description 16
- 239000004677 Nylon Substances 0.000 claims description 6
- 229920002614 Polyether block amide Polymers 0.000 claims description 6
- 229920001778 nylon Polymers 0.000 claims description 6
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 6
- KRALOLGXHLZTCW-UHFFFAOYSA-L calcium;2-acetyloxybenzoate Chemical compound [Ca+2].CC(=O)OC1=CC=CC=C1C([O-])=O.CC(=O)OC1=CC=CC=C1C([O-])=O KRALOLGXHLZTCW-UHFFFAOYSA-L 0.000 claims 2
- 230000003139 buffering effect Effects 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 description 28
- 239000000243 solution Substances 0.000 description 16
- 238000010586 diagram Methods 0.000 description 10
- 239000000463 material Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 206010011732 Cyst Diseases 0.000 description 2
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 2
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 2
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 2
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 2
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 2
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 206010002329 Aneurysm Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000013151 thrombectomy Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0063—Catheters; Hollow probes characterised by structural features having means, e.g. stylets, mandrils, rods or wires to reinforce or adjust temporarily the stiffness, column strength or pushability of catheters which are already inserted into the human body
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
技术领域Technical Field
本发明涉及中间导管组件技术领域,具体涉及一种中间导管组件及输送系统。The invention relates to the technical field of intermediate catheter components, and in particular to an intermediate catheter component and a conveying system.
背景技术Background Art
中间导管组件是介入治疗所常用的工具之一,尤其是在取栓和动脉瘤手术过程中,中间导管组件可以提供远端支撑,为其他其他介入材料的进入提供支持。The intermediate catheter assembly is one of the commonly used tools for interventional treatment, especially during thrombectomy and aneurysm surgery. The intermediate catheter assembly can provide distal support and provide support for the entry of other interventional materials.
现有的中间导管组件通常采用多层复合结构,形成单层的管壁。在其通过迂曲的血管时,可能会出现弯折以致于形成封闭的管腔。一但出现这种情况,这根中间导管组件就无法继续使用,就必须更换新的中间导管组件。Existing intermediate catheter components usually adopt a multi-layer composite structure to form a single-layer tube wall. When passing through a tortuous blood vessel, it may bend to form a closed lumen. Once this happens, the intermediate catheter component cannot be used any more and must be replaced with a new intermediate catheter component.
现有的中间导管组件靠近远端的一端的质地较软,其靠近近端的一端的质地较硬。在中间导管组件的使用过程中,很可能会由于术者的操作不当而导致将中间导管组件靠近远端的一端压瘪,中间导管组件的管腔变小,导致导管无法继续使用,这样的中间导管组件是无法继续使用的。The existing intermediate catheter assembly has a softer texture at one end near the distal end and a harder texture at the other end near the proximal end. During the use of the intermediate catheter assembly, the operator's improper operation may cause the distal end of the intermediate catheter assembly to collapse, causing the lumen of the intermediate catheter assembly to become smaller, making the catheter unusable. Such an intermediate catheter assembly cannot be used any more.
发明内容Summary of the invention
本发明提供了一种中间导管组件及输送系统,以解决现有中间导管组件在通过迂曲的血管时容易出现中间导管组件的中部弯折而导致管腔封闭,或中间导管组件靠近远端的一端被压瘪而导致管腔变小无法正常使用的技术问题。The present invention provides an intermediate catheter assembly and a delivery system to solve the technical problems that the middle part of the existing intermediate catheter assembly is easily bent when passing through a tortuous blood vessel, resulting in a closed lumen, or the end of the intermediate catheter assembly close to the distal end is compressed, resulting in a smaller lumen and inability to be used normally.
本发明公开一种中间导管组件,中间导管组件包括中间导管和抗弯部,中间导管的管壁具有至少一可供造影剂或生理盐水流通的注液通道;抗弯部设置于中间导管的外表面;抗弯部具有与注液通道连通的囊腔;囊腔的囊壁的厚度取值范围为0.02mm~0.05mm;通过注液通道向囊腔内注入造影剂或生理盐水使得囊腔膨胀形成缓冲囊,可以增加中间导管设有抗弯部处的抗弯折性能。The invention discloses an intermediate catheter component, which comprises an intermediate catheter and an anti-bending portion, wherein the tube wall of the intermediate catheter has at least one injection channel for contrast agent or physiological saline to flow; the anti-bending portion is arranged on the outer surface of the intermediate catheter; the anti-bending portion has a capsule cavity connected with the injection channel; the thickness of the capsule cavity wall ranges from 0.02 mm to 0.05 mm; contrast agent or physiological saline is injected into the capsule cavity through the injection channel to expand the capsule cavity to form a buffer capsule, thereby increasing the anti-bending performance of the intermediate catheter where the anti-bending portion is arranged.
进一步的,抗弯部呈管状或螺旋状,抗弯部至少包覆中间导管的一部分。Furthermore, the anti-bending portion is tubular or spiral, and the anti-bending portion at least covers a portion of the intermediate conduit.
进一步的,抗弯部的数量为多个,多个抗弯部围绕中间导管的轴线呈螺旋分布。Furthermore, there are multiple anti-bending portions, and the multiple anti-bending portions are distributed in a spiral shape around the axis of the intermediate conduit.
进一步的,抗弯部的数量为多个,多个抗弯部围绕中间导管的轴线均匀布设。Furthermore, there are multiple anti-bending parts, and the multiple anti-bending parts are evenly arranged around the axis of the intermediate conduit.
进一步的,抗弯部的数量为多个,多个抗弯部分别沿中间导管的轴线相对设置。Furthermore, there are multiple anti-bending parts, which are relatively arranged along the axis of the middle conduit.
进一步的,抗弯部的数量为多组,多组抗弯部沿中间导管的轴线依次间隔设置,相邻的两组抗弯部交叉设置。Furthermore, there are multiple groups of anti-bending parts, which are arranged in sequence and at intervals along the axis of the intermediate conduit, and two adjacent groups of anti-bending parts are arranged crosswise.
进一步的,囊腔的囊壁包括第一子囊壁和第二子囊壁,第一子囊壁位于靠近远端的位置,第二子囊壁位于靠近近端的位置;第一子囊壁的厚度比第二子囊壁的厚度薄。Furthermore, the capsule wall of the capsule cavity includes a first subcapsule wall and a second subcapsule wall, the first subcapsule wall is located near the distal end, and the second subcapsule wall is located near the proximal end; the thickness of the first subcapsule wall is thinner than that of the second subcapsule wall.
进一步的,第一子囊壁的外表面设置有多个胶点;和/或,第二子囊壁的外表面设置有多个胶点。Further, the outer surface of the first subcapsule wall is provided with a plurality of glue spots; and/or the outer surface of the second subcapsule wall is provided with a plurality of glue spots.
进一步的,抗弯部的材料采用Pebax、PET、尼龙中任一种或二者混合而成。Furthermore, the material of the anti-bending part is any one of Pebax, PET, nylon or a mixture of the two.
本发明还公开一种输送系统,该输送系统包括如上述任一项实施例所述的中间导管组件。The present invention also discloses a delivery system, which includes the intermediate catheter assembly as described in any one of the above embodiments.
本发明提供的中间导管组件及输送系统,可以实现以下技术效果:The intermediate catheter assembly and delivery system provided by the present invention can achieve the following technical effects:
在本实施例中,抗弯部存在非填充状态和填充状态的情况,这两种状态对中间导管的抗弯折性能均有所增益。采用本实施例的技术方案能够将中间导管的管壁做的更薄,这样的中间导管的通过性更好。In this embodiment, the anti-bending portion has a non-filled state and a filled state, and both states improve the anti-bending performance of the intermediate conduit. The technical solution of this embodiment can make the wall of the intermediate conduit thinner, so that the intermediate conduit has better passability.
当抗弯部设置于中间导管的外表面上时,且并未向抗弯部的囊腔内注入造影剂时,抗弯部高出中间导管的外表面。当抗弯部处于这种非填充状态时,抗弯部对中间导管的管壁的局部进行增厚,可以增强中间导管局部的抗弯性能,这是抗弯部处于非填充状态下增强中间导管的抗弯折性能。When the anti-bending portion is disposed on the outer surface of the intermediate catheter and contrast medium is not injected into the cavity of the anti-bending portion, the anti-bending portion is higher than the outer surface of the intermediate catheter. When the anti-bending portion is in such a non-filled state, the anti-bending portion thickens the local wall of the intermediate catheter, which can enhance the anti-bending performance of the local intermediate catheter. This is to enhance the anti-bending performance of the intermediate catheter when the anti-bending portion is in the non-filled state.
当然还可以向抗弯部的囊腔内注入造影剂形成缓冲囊,并使得抗弯部膨胀且处于填充状态,处于填充状态下的抗弯部高于中间导管的外表面,此时,处于填充状态下的抗弯部的硬度有所增加,要比中间导管的硬度硬。当中间导管将要弯折时,处于填充状态下的抗弯部在受到弯折压力起到缓冲作用,以降低中间导管被压瘪或弯折的风险。Of course, contrast agent can also be injected into the sac cavity of the anti-bending portion to form a buffer capsule, and the anti-bending portion is expanded and in a filled state. The anti-bending portion in the filled state is higher than the outer surface of the intermediate catheter. At this time, the hardness of the anti-bending portion in the filled state is increased and is harder than the hardness of the intermediate catheter. When the intermediate catheter is about to bend, the anti-bending portion in the filled state acts as a buffer under the bending pressure to reduce the risk of the intermediate catheter being crushed or bent.
以上的总体描述和下文中的描述仅是示例性和解释性的,不用于限制本发明。The foregoing general description and the following description are exemplary and explanatory only and are not intended to limit the present invention.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
一个或一个以上实施例通过与之对应的附图进行示例性说明,这些示例性说明和附图并不构成对实施例的限定,附图中具有相同参考数字标号的元件视为类似的元件,并且其中:One or more embodiments are exemplarily described by corresponding drawings, and these exemplary descriptions and drawings do not limit the embodiments. Elements with the same reference numerals in the drawings are regarded as similar elements, and wherein:
图1是本发明一种中间导管组件的一种实施例的剖面示意图一;FIG1 is a cross-sectional schematic diagram of an embodiment of an intermediate conduit assembly of the present invention;
图2是本发明一种中间导管组件的一种实施例的爆炸示意图;FIG2 is an exploded schematic diagram of an embodiment of an intermediate conduit assembly of the present invention;
图3是本发明一种中间导管组件的一种实施例的剖面示意图二;FIG3 is a second cross-sectional schematic diagram of an embodiment of an intermediate conduit assembly of the present invention;
图4是本发明一种中间导管组件的一种实施例的局部剖面示意图一;FIG4 is a partial cross-sectional schematic diagram of an embodiment of an intermediate conduit assembly of the present invention;
图5是本发明一种中间导管组件的一种实施例的示意图一;FIG5 is a schematic diagram of an embodiment of an intermediate conduit assembly of the present invention;
图6是本发明一种中间导管组件处于血管内的一种实施例的剖面示意图;FIG6 is a cross-sectional schematic diagram of an embodiment of an intermediate catheter assembly of the present invention being located within a blood vessel;
图7是本发明一种中间导管组件的一种实施例的示意图二;FIG7 is a second schematic diagram of an embodiment of an intermediate conduit assembly of the present invention;
图8是本发明一种中间导管组件的一种实施例的示意图三;FIG8 is a third schematic diagram of an embodiment of an intermediate conduit assembly of the present invention;
图9是本发明一种中间导管组件的一种实施例的侧视示意图;FIG9 is a side view of an embodiment of an intermediate conduit assembly of the present invention;
图10是本发明一种中间导管组件的一种实施例的局部剖面示意图二;FIG10 is a second partial cross-sectional schematic diagram of an embodiment of an intermediate conduit assembly of the present invention;
图11是本发明一种中间导管组件的一种实施例的局部剖面示意图三。FIG. 11 is a third partial cross-sectional schematic diagram of an embodiment of an intermediate conduit assembly of the present invention.
附图标记:Reference numerals:
1、中间导管;11、管腔;12、注液通道;13、连通孔;14、凹槽;2、抗弯部;21、囊腔;22、第一子囊壁;23、第二子囊壁;24、胶点。1. Intermediate catheter; 11. Tube cavity; 12. Liquid injection channel; 13. Connecting hole; 14. Groove; 2. Anti-bending portion; 21. Capsule cavity; 22. First subcapsule wall; 23. Second subcapsule wall; 24. Glue point.
具体实施方式DETAILED DESCRIPTION
为了能够更加详尽地了解本发明实施例的特点与技术内容,下面结合附图对本发明实施例的实现进行详细阐述,所附附图仅供参考说明之用,并非用来限定本发明实施例。在以下的技术描述中,为方便解释起见,通过多个细节以提供对所披露实施例的充分理解。然而,在没有这些细节的情况下,一个或多个实施例仍然可以实施。在其它情况下,为简化附图,熟知的结构和装置可以简化展示。In order to be able to understand the features and technical contents of the embodiments of the present invention in more detail, the implementation of the embodiments of the present invention is described in detail below in conjunction with the accompanying drawings. The attached drawings are for reference only and are not used to limit the embodiments of the present invention. In the following technical description, for the convenience of explanation, a full understanding of the disclosed embodiments is provided through multiple details. However, one or more embodiments can still be implemented without these details. In other cases, to simplify the drawings, well-known structures and devices can be simplified for display.
本发明实施例的说明书和权利要求书及上述附图中的术语“第一”、“第二”等是用于区别类似的对象,而不必用于描述特定的顺序或先后次序。应该理解这样使用的数据在适当情况下可以互换,以便这里描述的本发明实施例的实施例。此外,术语“包括”和“具有”以及他们的任何变形,意图在于覆盖不排他的包含。The terms "first", "second", etc. in the description and claims of the embodiments of the present invention and the above-mentioned drawings are used to distinguish similar objects, and are not necessarily used to describe a specific order or sequence. It should be understood that the terms used in this way can be interchanged where appropriate, so that the embodiments of the embodiments of the present invention described herein. In addition, the terms "including" and "having" and any variations thereof are intended to cover non-exclusive inclusions.
本发明实施例中,术语“上”、“下”、“内”、“中”、“外”、“前”、“后”等指示的方位或位置关系为基于附图所示的方位或位置关系。这些术语主要是为了更好地描述本发明实施例及其实施例,并非用于限定所指示的装置、元件或组成部分必须具有特定方位,或以特定方位进行构造和操作。并且,上述部分术语除了可以用于表示方位或位置关系以外,还可能用于表示其他含义,例如术语“上”在某些情况下也可能用于表示某种依附关系或连接关系。对于本领域普通技术人员而言,可以根据具体情况理解这些术语在本发明实施例中的具体含义。In the embodiments of the present invention, the terms "upper", "lower", "inside", "middle", "outside", "front", "back" and the like indicate directions or positional relationships based on the directions or positional relationships shown in the accompanying drawings. These terms are mainly used to better describe the embodiments of the present invention and its embodiments, and are not used to limit the indicated devices, elements or components to have a specific direction, or to be constructed and operated in a specific direction. Moreover, in addition to being used to indicate directions or positional relationships, some of the above terms may also be used to indicate other meanings. For example, the term "upper" may also be used to indicate a certain dependency or connection relationship in some cases. For those of ordinary skill in the art, the specific meanings of these terms in the embodiments of the present invention can be understood according to the specific circumstances.
另外,术语“设置”、“连接”、“固定”应做广义理解。例如,“连接”可以是固定连接,可拆卸连接,或整体式构造;可以是机械连接,或电连接;可以是直接相连,或者是通过中间媒介间接相连,又或者是两个装置、元件或组成部分之间内部的连通。对于本领域普通技术人员而言,可以根据具体情况理解上述术语在本发明实施例中的具体含义。In addition, the terms "disposed", "connected", and "fixed" should be understood in a broad sense. For example, "connected" can be a fixed connection, a detachable connection, or an integral structure; it can be a mechanical connection, or an electrical connection; it can be a direct connection, or an indirect connection through an intermediate medium, or it can be an internal connection between two devices, elements, or components. For those of ordinary skill in the art, the specific meanings of the above terms in the embodiments of the present invention can be understood according to specific circumstances.
除非另有说明,术语“多个”表示两个或两个以上,“多组”表示两组或两组以上。Unless otherwise specified, the term "plurality" means two or more and "plurality" means two or more.
需要说明的是,在不冲突的情况下,本发明实施例中的实施例及实施例中的特征可以相互组合。It should be noted that, in the absence of conflict, the embodiments and features in the embodiments of the present invention may be combined with each other.
在本发明中,远端是指在手术时远离术者的一端,近端是指在手术时靠近术者的一端。In the present invention, the distal end refers to the end away from the operator during surgery, and the proximal end refers to the end close to the operator during surgery.
第一实施例First embodiment
本实施例所提及的中间导管组件,如图1所示,该中间导管组件包括中间导管1、抗弯部2。中间导管1具有管腔11,中间导管1的管腔11可以供微导管通过。中间导管1的关闭内具有至少一个注液通道12,注液通道12可以供造影剂或生理盐水流通。抗弯部2设置于中间导管1的外表面上,抗弯部2具有囊腔21,该囊腔21与中间导管1上的注液通道12通过连通孔13连通。囊腔21的囊壁的厚度取值范围为0.02mm~0.05mm,通过控制囊腔21的囊壁厚度,优化了抗弯部2的弹力,提高了中间导管1的抗弯性能。The intermediate catheter assembly mentioned in this embodiment, as shown in FIG1 , includes an intermediate catheter 1 and an anti-bending portion 2. The intermediate catheter 1 has a lumen 11, and the lumen 11 of the intermediate catheter 1 can allow a microcatheter to pass through. The intermediate catheter 1 has at least one injection channel 12 in its closure, and the injection channel 12 can allow contrast agent or saline to circulate. The anti-bending portion 2 is arranged on the outer surface of the intermediate catheter 1, and the anti-bending portion 2 has a sac cavity 21, and the sac cavity 21 is connected to the injection channel 12 on the intermediate catheter 1 through a connecting hole 13. The thickness of the sac wall of the sac cavity 21 ranges from 0.02 mm to 0.05 mm. By controlling the thickness of the sac wall of the sac cavity 21, the elastic force of the anti-bending portion 2 is optimized, and the anti-bending performance of the intermediate catheter 1 is improved.
可选的,如图2所示,中间导管1的外表面具有与抗弯部2的形状相适配的凹槽14,凹槽14槽底具有与注液通道12连通的连通孔13,抗弯部2设置于凹槽14内,这样能够使抗弯部2处于非填充状态下与中间导管1的外表面平整,即抗弯部2不高于中间导管1的外表面。同时还可以让中间导管1设置有抗弯部2的部分的硬度与中间导管1未设置有抗弯部2的部分的硬度相同。Optionally, as shown in FIG2 , the outer surface of the intermediate conduit 1 has a groove 14 that matches the shape of the anti-bending portion 2, the bottom of the groove 14 has a connecting hole 13 that is connected to the injection channel 12, and the anti-bending portion 2 is arranged in the groove 14, so that the anti-bending portion 2 can be flat with the outer surface of the intermediate conduit 1 in a non-filled state, that is, the anti-bending portion 2 is not higher than the outer surface of the intermediate conduit 1. At the same time, the hardness of the portion of the intermediate conduit 1 provided with the anti-bending portion 2 can also be made the same as the hardness of the portion of the intermediate conduit 1 not provided with the anti-bending portion 2.
在本实施例中,若采用造影剂,则便于术者观察中间导管1在血管内的情况,当后期抗弯部2的囊腔21发生胀裂的情况,造影剂进入血管内,也便于人体代谢,避免了对人体造成损伤。同样的,若采用生理盐水,当后期抗弯部2的囊腔21发生胀裂的情况,生理盐水进入血管内,可能会增加小便次数,避免了对人体造成损伤。在本发明中,后续以造影剂为例进行描述。In this embodiment, if contrast agent is used, it is convenient for the operator to observe the situation of the intermediate catheter 1 in the blood vessel. When the cyst cavity 21 of the late anti-bending portion 2 ruptures, the contrast agent enters the blood vessel, which is also convenient for human metabolism and avoids damage to the human body. Similarly, if physiological saline is used, when the cyst cavity 21 of the late anti-bending portion 2 ruptures, the physiological saline enters the blood vessel, which may increase the frequency of urination and avoid damage to the human body. In the present invention, contrast agent is used as an example for description.
在本实施例中,抗弯部2存在非填充状态和填充状态的情况,这两种状态对中间导管1的抗弯折性能均有所增益。采用本实施例的技术方案能够将中间导管1的管壁做的更薄,这样的中间导管1的通过性更好。In this embodiment, the anti-bending portion 2 has a non-filled state and a filled state, and both states improve the anti-bending performance of the intermediate conduit 1. The technical solution of this embodiment can make the wall of the intermediate conduit 1 thinner, so that the intermediate conduit 1 has better passability.
当抗弯部2设置于中间导管1的外表面上时,且并未向抗弯部2的囊腔21内注入造影剂时,抗弯部2高出中间导管1的外表面。当抗弯部2处于这种非填充状态时,抗弯部2对中间导管1的管壁的局部进行增厚,可以增强中间导管1局部的抗弯性能,这是抗弯部2处于非填充状态下增强中间导管1的抗弯折性能。When the anti-bending portion 2 is disposed on the outer surface of the intermediate catheter 1 and no contrast agent is injected into the cavity 21 of the anti-bending portion 2, the anti-bending portion 2 is higher than the outer surface of the intermediate catheter 1. When the anti-bending portion 2 is in this non-filled state, the anti-bending portion 2 thickens the local wall of the intermediate catheter 1, which can enhance the local anti-bending performance of the intermediate catheter 1. This is the anti-bending portion 2 in the non-filled state to enhance the anti-bending performance of the intermediate catheter 1.
当然还可以向抗弯部2的囊腔21内注入造影剂形成缓冲囊,并使得抗弯部2膨胀且处于填充状态,处于填充状态下的抗弯部2高于中间导管1的外表面,此时,处于填充状态下的抗弯部2的硬度有所增加,要比中间导管1的硬度硬。当中间导管1将要弯折时,处于填充状态下的抗弯部2在受到弯折压力起到缓冲作用,以降低中间导管1被压瘪或弯折的风险。Of course, contrast agent can also be injected into the sac cavity 21 of the anti-bending portion 2 to form a buffer capsule, and the anti-bending portion 2 is expanded and in a filled state. The anti-bending portion 2 in the filled state is higher than the outer surface of the intermediate catheter 1. At this time, the hardness of the anti-bending portion 2 in the filled state is increased and is harder than the hardness of the intermediate catheter 1. When the intermediate catheter 1 is about to bend, the anti-bending portion 2 in the filled state plays a buffering role under the bending pressure, so as to reduce the risk of the intermediate catheter 1 being crushed or bent.
具体的,抗弯部2的用法有两种。第一种,直接通过注液通道12向抗弯部2的囊腔21内注入造影剂,可以增加中间导管1设有抗弯部2处的抗弯折性能,属于预防中间导管1发生压瘪或弯折的情况。第二种,中间导管组件通过迂曲的血管已经发生了弯折并导致管腔11封闭的情况,可以通过注液通道12向抗弯部2的囊腔21内缓慢注入造影剂,造影剂可以使弯折部慢慢膨胀。此时,随着弯折部的膨胀,可以使得中间导管1的弯折部分的两端被拉直,以解决管腔11封闭的问题。Specifically, there are two ways to use the anti-bending portion 2. The first is to directly inject contrast agent into the cavity 21 of the anti-bending portion 2 through the injection channel 12, which can increase the anti-bending performance of the intermediate catheter 1 where the anti-bending portion 2 is provided, which is to prevent the intermediate catheter 1 from being crushed or bent. The second is that in the case where the intermediate catheter assembly has been bent through a tortuous blood vessel and the lumen 11 has been closed, the contrast agent can be slowly injected into the cavity 21 of the anti-bending portion 2 through the injection channel 12, and the contrast agent can slowly expand the bent portion. At this time, as the bent portion expands, the two ends of the bent portion of the intermediate catheter 1 can be straightened to solve the problem of the closed lumen 11.
上述的技术方案可以增强中间导管1的抗弯折性能,还可以优化对抗弯部2的形状及设置方式对中间导管1的抗弯折性能进一步提升,具体如下:The above technical solution can enhance the anti-bending performance of the intermediate conduit 1, and can also optimize the shape and arrangement of the anti-bending portion 2 to further enhance the anti-bending performance of the intermediate conduit 1, as follows:
可选的,如图1所示,抗弯部2呈管状,呈管状的抗弯部2套设于整根中间导管1,并将整根中间导管1通体包覆。这样的设置可以增强整根中间导管1的抗弯折性能,这样的设置适用于转弯比较多的、迂曲的血管。Optionally, as shown in Fig. 1, the anti-bending portion 2 is tubular, and the tubular anti-bending portion 2 is sleeved on the entire intermediate conduit 1 and covers the entire intermediate conduit 1. Such a configuration can enhance the anti-bending performance of the entire intermediate conduit 1, and such a configuration is suitable for tortuous blood vessels with many turns.
可选的,如图3所示,抗弯部2呈管状,呈管状的抗弯部2套设于中间导管1,并将中间导管1的一部分进行包覆。当然还可以在中间导管1上设置多个抗弯部2,多个抗弯部2沿中间导管1的轴线依次间隔设置。这样的设置可以增强中间导管1的多段局部的抗弯折性能,这样的设置更适用于转弯比较多的、迂曲的血管,更加具有针对性。当中间导管1在血管内需要转弯时,为了避免中间导管1发生弯折,仅需对抗弯部2填充造影剂,并使得抗弯部2处于填充状态,处于填充状态的抗弯部2增加了中间导管1的柔韧度、抗弯性能,可以让中间导管1顺利地通过血管的转弯处。Optionally, as shown in FIG3 , the anti-bending portion 2 is tubular, and the tubular anti-bending portion 2 is sleeved on the intermediate catheter 1, and covers a portion of the intermediate catheter 1. Of course, multiple anti-bending portions 2 can also be provided on the intermediate catheter 1, and the multiple anti-bending portions 2 are arranged in sequence along the axis of the intermediate catheter 1. Such an arrangement can enhance the anti-bending performance of multiple sections of the intermediate catheter 1, and such an arrangement is more suitable for tortuous blood vessels with more turns, and is more targeted. When the intermediate catheter 1 needs to turn in the blood vessel, in order to avoid the intermediate catheter 1 from bending, it is only necessary to fill the anti-bending portion 2 with contrast agent, and make the anti-bending portion 2 in a filled state. The anti-bending portion 2 in a filled state increases the flexibility and anti-bending performance of the intermediate catheter 1, allowing the intermediate catheter 1 to pass smoothly through the bend of the blood vessel.
可选的,如图4所示,抗弯部2呈螺旋状,呈螺旋状的抗弯部2套设于中间导管1上,并将中间导管1的一部分进行包覆。当然还可以在中间导管1上设置多个呈螺旋状的抗弯部2,多个抗弯部2沿中间导管1的轴线依次间隔设置。相对比上述采用抗弯部2将整根中间导管1通体进行包覆的技术方案而言,这样的设置同样可以增强中间导管1的多段局部的抗弯折性能,适用于转弯比较多的、迂曲的血管,当中间导管1在血管内需要转弯时,为了避免中间导管1发生弯折,仅需对抗弯部2填充造影剂,并使得抗弯部2处于填充状态,处于填充状态的抗弯部2增加了中间导管1的柔韧度、抗弯性能,可以让中间导管1顺利地通过血管的转弯处。在本技术方案中,呈螺旋状的抗弯部2不仅保证了其抗弯性能,还节约了材料、降低了制造成本。Optionally, as shown in FIG4 , the anti-bending portion 2 is spirally shaped, and the spirally shaped anti-bending portion 2 is sleeved on the intermediate conduit 1, and covers a part of the intermediate conduit 1. Of course, multiple spirally shaped anti-bending portions 2 can also be arranged on the intermediate conduit 1, and the multiple anti-bending portions 2 are arranged in sequence along the axis of the intermediate conduit 1. Compared with the above-mentioned technical solution of using the anti-bending portion 2 to cover the entire intermediate conduit 1, such a setting can also enhance the anti-bending performance of multiple sections of the intermediate conduit 1, and is suitable for tortuous blood vessels with more turns. When the intermediate conduit 1 needs to turn in the blood vessel, in order to avoid the intermediate conduit 1 from bending, it is only necessary to fill the anti-bending portion 2 with contrast agent, and make the anti-bending portion 2 in a filled state. The anti-bending portion 2 in a filled state increases the flexibility and anti-bending performance of the intermediate conduit 1, and allows the intermediate conduit 1 to pass smoothly through the turning of the blood vessel. In this technical solution, the spirally shaped anti-bending portion 2 not only ensures its anti-bending performance, but also saves materials and reduces manufacturing costs.
可选的,如图5所示,抗弯部2呈块状,抗弯部2可以是方块状,也可以是圆块状,在本实施例中,只要抗弯部2呈块状即可,不对抗弯部2的块体形状进一步限定。在本实施例中,抗弯部2的数量为多个,多个抗弯部2围绕中间导管1的轴线呈螺旋分布。与上述呈螺旋状的抗弯部2的技术方案相比,将多个呈块状的抗弯部2围绕中间导管1的轴线呈螺旋分布不仅可以增加中间导管1的抗弯性能,还可以使抗弯部2的使用更加具有针对性。如图6所示为一种向右弯曲的血管,在面临这种情况时,中间导管1靠近一端的一端也随着血管向右弯曲。图6中虚线表示血管的弯曲区域,中间导管1位于弯曲区域的这一段属于弯曲部,处于弯曲部上的多个抗弯部2相互配合对中间导管1的弯曲部的抗弯性能进行增强,具体表现为,向位于中间导管1左侧的抗弯部2的囊腔21内填充造影剂,并使得造影剂填充满囊腔21以使得抗弯部2膨胀处于填充状态。同时,向位于中间导管1右侧的抗弯部2的囊腔21内填充造影剂,并使得造影剂填充囊腔21的一半空间以使得抗弯部2膨胀处于半填充状态。同时使得中间导管1一侧的抗弯部2处于填充状态、中间导管1另一侧的抗弯部2处于半填充状态,这样的彼此配合可以让中间导管1的弯曲段具有韧性,提高了导管的抗弯折能力。Optionally, as shown in FIG5 , the anti-bending portion 2 is block-shaped. The anti-bending portion 2 can be square or round. In the present embodiment, as long as the anti-bending portion 2 is block-shaped, the block shape of the anti-bending portion 2 is not further limited. In the present embodiment, the number of the anti-bending portions 2 is multiple, and the multiple anti-bending portions 2 are spirally distributed around the axis of the intermediate conduit 1. Compared with the technical solution of the above-mentioned spiral anti-bending portion 2, the multiple block-shaped anti-bending portions 2 are spirally distributed around the axis of the intermediate conduit 1, which can not only increase the anti-bending performance of the intermediate conduit 1, but also make the use of the anti-bending portion 2 more targeted. As shown in FIG6 , a blood vessel that bends to the right is shown. When facing this situation, the end of the intermediate conduit 1 close to one end also bends to the right along with the blood vessel. The dotted line in FIG6 indicates the bending area of the blood vessel. The section of the intermediate catheter 1 located in the bending area belongs to the bending portion. The multiple anti-bending portions 2 on the bending portion cooperate with each other to enhance the anti-bending performance of the bending portion of the intermediate catheter 1. Specifically, the contrast agent is filled into the sac cavity 21 of the anti-bending portion 2 located on the left side of the intermediate catheter 1, and the contrast agent fills the sac cavity 21 so that the anti-bending portion 2 expands and is in a filled state. At the same time, the contrast agent is filled into the sac cavity 21 of the anti-bending portion 2 located on the right side of the intermediate catheter 1, and the contrast agent fills half of the space of the sac cavity 21 so that the anti-bending portion 2 expands and is in a half-filled state. At the same time, the anti-bending portion 2 on one side of the intermediate catheter 1 is in a filled state, and the anti-bending portion 2 on the other side of the intermediate catheter 1 is in a half-filled state. Such cooperation can make the bending section of the intermediate catheter 1 tough and improve the anti-bending ability of the catheter.
可选的,如图7所示,抗弯部2呈块状,且抗弯部2的数量为多个,多个抗弯部2分别沿中间导管1的轴线相对设置。一部分抗弯部2设置于中间导管1的一侧,另一部分抗弯部2设置于中间导管1的另一侧,这样可以对中间导管1的两侧进行加厚,以改善中间导管1的抗弯折性能。这样的设置不仅保证了其抗弯性能,还节约了材料、降低了制造成本,还能更加适用于连续转弯的、迂曲的血管内。Optionally, as shown in FIG7 , the anti-bending portion 2 is block-shaped, and the number of the anti-bending portions 2 is multiple, and the multiple anti-bending portions 2 are respectively arranged relatively along the axis of the intermediate catheter 1. A part of the anti-bending portion 2 is arranged on one side of the intermediate catheter 1, and another part of the anti-bending portion 2 is arranged on the other side of the intermediate catheter 1, so that both sides of the intermediate catheter 1 can be thickened to improve the anti-bending performance of the intermediate catheter 1. Such an arrangement not only ensures its anti-bending performance, but also saves materials, reduces manufacturing costs, and is more suitable for continuous turning and tortuous blood vessels.
可选的,如图8、图9所示,抗弯部2的数量为多组,多组抗弯部2沿中间导管1的轴线依次间隔设置,相邻的两组抗弯部2交叉设置。每组抗弯部2均包括多个抗弯部2,且抗弯部2呈块状,多个抗弯部2围绕中间导管1的轴线均匀布设。当中间导管1处于血管的弯曲区域时,通过处于弯曲部的多组抗弯部2均处于填充状态、半填充状态之间的配合能够将中间导管1的弯曲部所受到的弯折力进行缓冲,避免了弯曲部发生弯折的风险,增强了中间导管1的抗弯折性能。Optionally, as shown in FIG8 and FIG9, the number of the anti-bending parts 2 is multiple groups, and the multiple groups of anti-bending parts 2 are arranged in sequence along the axis of the intermediate conduit 1, and two adjacent groups of anti-bending parts 2 are arranged crosswise. Each group of anti-bending parts 2 includes multiple anti-bending parts 2, and the anti-bending parts 2 are block-shaped, and the multiple anti-bending parts 2 are evenly arranged around the axis of the intermediate conduit 1. When the intermediate conduit 1 is in the bending area of the blood vessel, the bending force on the bending part of the intermediate conduit 1 can be buffered by the coordination between the multiple groups of anti-bending parts 2 in the bending part being in the filled state and the semi-filled state, thereby avoiding the risk of bending of the bending part and enhancing the anti-bending performance of the intermediate conduit 1.
在上述可选的技术方案中,抗弯部2的数量为多个时,注液通道12的数量与抗弯部2的数量相同。每个抗弯部2分别与一个注液通道1连通。这样可以避免出现通过一个注液通道1而使得多个抗弯部2进行膨胀的现象。In the above optional technical solution, when there are multiple anti-bending parts 2, the number of injection channels 12 is the same as the number of anti-bending parts 2. Each anti-bending part 2 is connected to one injection channel 1. In this way, the phenomenon of multiple anti-bending parts 2 expanding through one injection channel 1 can be avoided.
上述可选的技术方案任选其一即可。You can select any one of the above optional technical solutions.
当然,除了用抗弯部2将整根中间导管1通体包覆的技术方案以外的其他可选的技术方案还存在另一种效果,具体为,术者可以根据术中具体的情况对多个弯折部进行选择性填充。例如,在中间导管1通过血管的第一个转弯时,术者可以仅对处于血管弯曲区域的抗弯部2进行填充,当抗弯部2已经通过第一个转弯时,术者可以将已经填充过的抗弯部2进行抽液处理,并使得抗弯部2处于非填充状态。而重新对下一个处于血管弯曲区域的抗弯部2进行填充。这样的设置使得术者的操作灵活性更强,也更加具有针对性。Of course, in addition to the technical solution of covering the entire intermediate catheter 1 with the anti-bending portion 2, other optional technical solutions have another effect, specifically, the operator can selectively fill multiple bending portions according to the specific situation during the operation. For example, when the intermediate catheter 1 passes through the first turn of the blood vessel, the operator can only fill the anti-bending portion 2 in the bending area of the blood vessel. When the anti-bending portion 2 has passed the first turn, the operator can drain the already filled anti-bending portion 2 and make the anti-bending portion 2 in a non-filled state. And refill the next anti-bending portion 2 in the bending area of the blood vessel. Such a setting makes the operator's operation more flexible and more targeted.
第二实施例Second embodiment
本实施例同样提出了一种中间导管组件,第二实施例是基于第一实施例的进一步改进,改进之处在于囊腔21的囊壁的结构,具体如下:This embodiment also proposes an intermediate catheter assembly. The second embodiment is a further improvement on the first embodiment. The improvement lies in the structure of the sac wall of the sac cavity 21, which is as follows:
可选的,如图10所示,抗弯部2的材料采用Pebax、PET、尼龙中任一种或二者混合而成,抗弯部2的柔软度比中间导管1的柔软度更软。而囊腔21的囊壁包括第一子囊壁22和第二子囊壁23,第一子囊壁22设置于抗弯部2靠近远端的位置,第二子囊壁23设置于抗弯部2靠近近端的位置,第一子囊壁22的厚度取值范围为0.02mm~0.03mm,第二子囊壁23的厚度取值范围为0.04mm~0.05mm,且二者之间的连接处自第一子囊壁22向第二子囊壁23均匀过渡,第一子囊壁22的厚度比第二子囊壁23的厚度薄。Optionally, as shown in FIG10 , the material of the anti-bending portion 2 is made of any one of Pebax, PET, and nylon or a mixture of the two, and the softness of the anti-bending portion 2 is softer than that of the intermediate catheter 1. The capsule wall of the capsule cavity 21 includes a first subcapsule wall 22 and a second subcapsule wall 23, the first subcapsule wall 22 is arranged near the distal end of the anti-bending portion 2, and the second subcapsule wall 23 is arranged near the proximal end of the anti-bending portion 2, the thickness of the first subcapsule wall 22 ranges from 0.02 mm to 0.03 mm, the thickness of the second subcapsule wall 23 ranges from 0.04 mm to 0.05 mm, and the connection between the two is uniformly transitioned from the first subcapsule wall 22 to the second subcapsule wall 23, and the thickness of the first subcapsule wall 22 is thinner than the thickness of the second subcapsule wall 23.
可选的,如图11所示,该可选的技术方案是上述可选技术方案的进一步改良。第一子囊壁22靠近远端的一端的厚度取值范围为0.02mm~0.03mm,第二子囊壁23靠近近端的一端的厚度取值范围为0.04mm~0.05mm,囊腔21的囊壁厚度自第一子囊壁22靠近远端的一端向第二子囊壁23靠近近端的一端逐渐增大。Optionally, as shown in FIG11 , this optional technical solution is a further improvement of the above optional technical solution. The thickness of the end of the first subcapsule wall 22 close to the distal end is in the range of 0.02 mm to 0.03 mm, and the thickness of the end of the second subcapsule wall 23 close to the proximal end is in the range of 0.04 mm to 0.05 mm. The thickness of the capsule wall of the capsule cavity 21 gradually increases from the end of the first subcapsule wall 22 close to the distal end to the end of the second subcapsule wall 23 close to the proximal end.
上述两种可选的技术方案任选其一即可。You can choose any one of the two optional technical solutions mentioned above.
在本实施例中,采用上述的技术方案可以使本实施例的中间导管组件具有两种效果。第一种效果是,处于非填充状态下的抗弯部2的第一子囊壁22靠近远端且第一子囊壁22比第二子囊壁23更薄,并结合抗弯部的材料,这样可以使中间导管1的柔顺性更好,更容易贴合血管内壁。第二种效果是,为了减少对血管的损伤需要向囊腔21内缓慢注入造影剂,而随着造影剂的缓慢注入,靠近第一子囊壁22部位的囊腔21更容易膨胀起来,这样相对于等壁厚的囊壁而言,膨胀效果更好。In this embodiment, the above-mentioned technical solution can make the intermediate catheter assembly of this embodiment have two effects. The first effect is that the first sub-capsule wall 22 of the anti-bending part 2 in the non-filled state is close to the distal end and the first sub-capsule wall 22 is thinner than the second sub-capsule wall 23, and combined with the material of the anti-bending part, the flexibility of the intermediate catheter 1 is better and it is easier to fit the inner wall of the blood vessel. The second effect is that in order to reduce the damage to the blood vessel, the contrast agent needs to be slowly injected into the capsule cavity 21, and with the slow injection of the contrast agent, the capsule cavity 21 near the first sub-capsule wall 22 is easier to expand, so that the expansion effect is better than that of the capsule wall with the same wall thickness.
第三实施例Third embodiment
本实施例同样提出了一种中间导管组件,第三实施例是基于第二实施例的进一步改进,具体如下:This embodiment also proposes an intermediate conduit assembly. The third embodiment is a further improvement based on the second embodiment, and is specifically as follows:
可选的,如图11所示,第一子囊壁22的外表面设置有多个呈半球状的胶点24。胶点24的材料采用Pebax、PET、尼龙中任一种或二者混合而成,可以保障胶点24的柔软度和抗弯部2的柔软度相同。Optionally, as shown in Fig. 11, a plurality of hemispherical glue dots 24 are provided on the outer surface of the first subcapsule wall 22. The glue dots 24 are made of Pebax, PET, nylon or a mixture of the two, which can ensure that the softness of the glue dots 24 is the same as that of the anti-bending portion 2.
可选的,如图11所示,第二子囊壁23的外表面设置有多个呈半球状的胶点24。胶点24的材料采用Pebax、PET、尼龙中任一种或二者混合而成,可以保障胶点24的柔软度和抗弯部2的柔软度相同。Optionally, as shown in Fig. 11, a plurality of hemispherical glue dots 24 are provided on the outer surface of the second subcapsule wall 23. The glue dots 24 are made of any one of Pebax, PET, and nylon or a mixture of the two, which can ensure that the softness of the glue dots 24 is the same as that of the anti-bending portion 2.
可选的,如图11所示,还可以将上述两种技术方案进行整合,第一子囊壁22的外表面及第二子囊壁23的外表面均设置有多个呈半球状的胶点24。胶点24的材料采用Pebax、PET、尼龙中任一种或二者混合而成,可以保障胶点24的柔软度和抗弯部2的柔软度相同。Optionally, as shown in FIG11 , the above two technical solutions can be integrated, and the outer surface of the first subcapsule wall 22 and the outer surface of the second subcapsule wall 23 are both provided with a plurality of hemispherical glue dots 24. The material of the glue dots 24 is any one of Pebax, PET, and nylon or a mixture of the two, which can ensure that the softness of the glue dots 24 is the same as the softness of the anti-bending portion 2.
上述三种可选的技术方案任选其一即可。与现有技术相比,本实施例所公开的中间导管组件的抗弯部2的外表面上具有胶点24。当中间导管1在血管内停止移动,对中间导管1上处于血管弯曲区域的抗弯部2进行填充造影剂,并使得抗弯部2处于填充状态。此时,抗弯部2的胶点24可以与血管内壁接触,起锚点作用,可以增加中间导管1在血管内的稳定性,便于术者的其他操作。Any one of the above three optional technical solutions can be selected. Compared with the prior art, the outer surface of the anti-bending portion 2 of the intermediate catheter assembly disclosed in this embodiment has a glue point 24. When the intermediate catheter 1 stops moving in the blood vessel, the anti-bending portion 2 of the intermediate catheter 1 in the blood vessel bending area is filled with contrast agent, and the anti-bending portion 2 is in a filled state. At this time, the glue point 24 of the anti-bending portion 2 can contact the inner wall of the blood vessel, act as an anchor point, increase the stability of the intermediate catheter 1 in the blood vessel, and facilitate other operations of the operator.
第四实施例Fourth embodiment
本发明还公开一种输送系统(图中未示出)。第四实施例所公开的该输送系统包括第一至第三实施例中任一项实施例中的中间导管组件。The present invention further discloses a delivery system (not shown in the figure). The delivery system disclosed in the fourth embodiment includes the intermediate catheter assembly in any one of the first to third embodiments.
以上描述和附图充分地示出了本发明的实施例,以使本领域的技术人员能够实践它们。其他实施例可以包括结构的以及其他的改变。实施例仅代表可能的变化。除非明确要求,否则单独的部件和功能是可选的,并且操作的顺序可以变化。一些实施例的部分和特征可以被包括在或替换其他实施例的部分和特征。本发明的实施例并不局限于上面已经描述并在附图中示出的结构,并且可以在不脱离其范围进行各种修改和改变。本发明的范围仅由所附的权利要求来限制。The above description and the accompanying drawings fully illustrate the embodiments of the present invention so that those skilled in the art can practice them. Other embodiments may include structural and other changes. The embodiments represent only possible variations. Unless explicitly required, individual components and functions are optional, and the order of operations may vary. Parts and features of some embodiments may be included in or replace parts and features of other embodiments. The embodiments of the present invention are not limited to the structures described above and shown in the accompanying drawings, and various modifications and changes may be made without departing from the scope thereof. The scope of the present invention is limited only by the appended claims.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202411161768.7A CN118662754B (en) | 2024-08-23 | 2024-08-23 | Intermediate catheter assembly and conveying system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202411161768.7A CN118662754B (en) | 2024-08-23 | 2024-08-23 | Intermediate catheter assembly and conveying system |
Publications (2)
Publication Number | Publication Date |
---|---|
CN118662754A true CN118662754A (en) | 2024-09-20 |
CN118662754B CN118662754B (en) | 2024-12-20 |
Family
ID=92732885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202411161768.7A Active CN118662754B (en) | 2024-08-23 | 2024-08-23 | Intermediate catheter assembly and conveying system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118662754B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070112407A1 (en) * | 2005-11-14 | 2007-05-17 | Boston Scientific Scimed, Inc. | Twisting bifurcation delivery system |
CN111150923A (en) * | 2020-02-20 | 2020-05-15 | 玮铭医疗器械(上海)有限公司 | A balloon catheter suitable for curved blood vessels |
CN114099910A (en) * | 2020-08-28 | 2022-03-01 | 德普伊新特斯产品公司 | Improved flexible balloon catheter |
US20220379098A1 (en) * | 2021-03-01 | 2022-12-01 | Farajallah Mounir Hanna al-kass | Fenestrated infusion balloon catheter and methods of use |
CN118304543A (en) * | 2024-06-07 | 2024-07-09 | 北京久事神康医疗科技有限公司 | Enhancement mode microcatheter and conveying system |
CN118416368A (en) * | 2024-07-02 | 2024-08-02 | 北京久事神康医疗科技有限公司 | An enhanced intermediate catheter assembly and delivery system |
-
2024
- 2024-08-23 CN CN202411161768.7A patent/CN118662754B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070112407A1 (en) * | 2005-11-14 | 2007-05-17 | Boston Scientific Scimed, Inc. | Twisting bifurcation delivery system |
CN111150923A (en) * | 2020-02-20 | 2020-05-15 | 玮铭医疗器械(上海)有限公司 | A balloon catheter suitable for curved blood vessels |
CN114099910A (en) * | 2020-08-28 | 2022-03-01 | 德普伊新特斯产品公司 | Improved flexible balloon catheter |
US20220379098A1 (en) * | 2021-03-01 | 2022-12-01 | Farajallah Mounir Hanna al-kass | Fenestrated infusion balloon catheter and methods of use |
CN118304543A (en) * | 2024-06-07 | 2024-07-09 | 北京久事神康医疗科技有限公司 | Enhancement mode microcatheter and conveying system |
CN118416368A (en) * | 2024-07-02 | 2024-08-02 | 北京久事神康医疗科技有限公司 | An enhanced intermediate catheter assembly and delivery system |
Also Published As
Publication number | Publication date |
---|---|
CN118662754B (en) | 2024-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111465420B (en) | Improved catheter and apparatus and system incorporating same | |
US20240366917A1 (en) | Helical balloon catheter | |
JP6185113B2 (en) | Non-circular inner lumen guide catheter with auxiliary variable support | |
US7753919B2 (en) | Wire for removing intravascular foreign body and medical instrument | |
KR101910207B1 (en) | Trimmable catheter including distal portion stability features | |
JP4308007B2 (en) | Intravascular microcatheter having a proximal shaft comprising a hypotube with a transition section | |
US6508805B1 (en) | Intravascular catheter with composite reinforcement | |
JP2023053133A (en) | blood pump with reinforced catheter | |
US7972323B1 (en) | Steerable device for introducing diagnostic and therapeutic apparatus into the body | |
JP4562197B2 (en) | Balloon catheter assembly | |
US20030191451A1 (en) | Reinforced catheter system | |
JP7547075B2 (en) | Inflation lumen kink protection and balloon contour | |
JP2005312894A (en) | Stent with flexible element | |
US20080114303A1 (en) | Guidewire | |
JPH07178176A (en) | Catheter | |
CN117980028A (en) | Nerve vascular catheter with enhanced flexibility | |
JP2022048170A5 (en) | ||
CN114618067A (en) | Catheter design for enhanced column strength | |
CN118662754A (en) | Intermediate catheter assembly and conveying system | |
CN108904007A (en) | A kind of cranium endoprosthesis | |
US20240115278A1 (en) | Bevel tip expandable mouth catheter with reinforcing ring | |
JP3944395B2 (en) | Cerebral artery catheter and catheter device | |
WO2003086519A1 (en) | Reinforced catheter system | |
CN221600043U (en) | A blood flow blocking device for vascular intervention and aneurysm surgery auxiliary equipment | |
WO2024139986A1 (en) | Balloon sheath catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |